Skip to content

Eli Lilly LLY Debt Repayments

Debt Repayments at other companies

Amgen logo
AmgenAMGN
$833M-66.7%
Cardinal Health logo
Cardinal HealthCAH
$113M+927%
McKesson logo
McKessonMCK
$8M-11.1%
Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
$5M
Cencora logo
CencoraCOR
$217.78M-56.8%

Other financials

Income statement

See full
Revenue$19.8B+55.5%
Gross profit$16.2B+54.4%
Net income$7.4B+168%
EPS (diluted)$8.26+170%

Balance sheet

See full
Cash & equivalents$5.3B+70.8%
Total debt$43.4B+12.6%
Total equity$31.2B+97.9%
Total assets$116.58B+30.4%

Cash flow

See full
Operating cash flow$5.3B+220%
CapEx$2.3B+54.0%
Free cash flow$3.0B+1,828%

Valuation

See full
Market cap$1.07T+51.7%
Enterprise value$1.11T+49.3%
P/E42.3×-8.8×
P/S14.8×+1.6×

Profitability

See full
Gross margin82.8%+1.1pp
Net margin35%+12.3pp
FCF margin16.4%+8.7pp

Returns & leverage

See full
Return on equity107.6%+29.9pp
Debt / equity1.4×-1.1×
Current ratio1.5×+0.1×

Where this comes from

Reported directly by Eli Lilly in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermDebt.

The official record: Eli Lilly’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eli Lilly's debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eli Lilly's debt repayments?
Eli Lilly (LLY) reported debt repayments of $750M in Q1 2026.
What is the long-term trend for Eli Lilly's debt repayments?
Over 2 years (2021 to 2024), Eli Lilly's debt repayments has grown at a -41.0% compound annual growth rate (CAGR), from $1.91B to $664M.
What does debt repayments mean?
Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.